American Cancer Society publications

Acknowledgements. We are especially grateful to E. Deutsch (University of Cincinnatti), S. C. Srivastava and A. Packard (Brookhaven National Laboratories), and B. DePamphilis (Massachusetts Institute of Technology), who have made the results of experimental work available to us prior to publication. Work in our laboratory was supported by the American Cancer Society, Massachusetts Division and PHS Grant CA24344. 

Received April 26, 1963. Work supported by the American Cancer Society (Research Grant P-177) and the U.S. Public Health Service (Research Grant AM 01397 and Research Career Program Award K3-GM-4124). 

Religious, charitable, public service, or fraternal organizations. Central to these organizations is a cause or belief that brings members and supporters together. Examples include the American Cancer Society or the National Wildlife Fmmdation. 

Jason Kass, Mark Vandenberg, and Nicholas Chester, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, for their work on CKII. Work at Cold Spring Harbor is supported by a Cancer Research Fund of the Damon-Runyon-Walter Winchell Foundation Fellowship, DRG-1193 (to J.L.H.), by grant CB-72 from the American Cancer Society (to D.R.M.) and by grant AG10208 from the Public Health Service (to D.R.M.). 

We would like to acknowledge with grateful thanks the financial support of the American Cancer Society, Inc., Grants P-106 and P107, and of the U. S. Public Health Service, National Institutes of Health, Grant CA-07638. One of us (W. H. Fishman) is the recipient of a Research Career Award of the National Institutes of Health, U.S.P.H.S., Grant CA-K6-18,453. 

Self-examination of the skin places the responsibilities of identification on the individual. Identification of early melanoma allows the opportunity to treat the lesions when they are thin and curable. Educational pamphlets describing the method of self-examination (Table 133-2) for the public are available through the American Cancer Society, the American Academy of Dermatology, and the Skin Cancer Foundation. If a newly discovered pigmented lesion is identified or if a preexisting pigmented lesion changes, the individual should be evaluated by a physician immediately. 

Cancer is becoming a very serious public health problem in the USA and other developed countries. The American Cancer Society estimates every year the number of new cancer cases and deaths expected in the USA and compiles the most recent cancer incidence data from the National Cancer Institute and mortaUty data from National Cancer for Health Statistics. A total number of 1372910 new cancer cases and 570280 deaths were expected in the USA in 2005. Currently, about 25% of deaths in the USA are due only to cancer [1]. 

Cancer is a group of diseases that result from abnormal and prolific cellular division. Based on current U.S. National Cancer Institute s Surveillance Epidemiology and End Results (SEER) of cancer prevalence, it is estimated that more than 10 million people were living with cancer in the United States in 2005 (NCI 2008). The American Cancer Society predicts that 1 in 2 males and 1 in 3 females will develop some type of cancer in their lifetime, and that 1 in 4 males and 1 in 5 females is at risk of dying from this disease (NCI 2007a,b). Cancer is undoubtedly a substantial threat to public health. 

As medicine moves from reactive to preventive, and preventive to enhancement and physical excellence, it will be perfectly respectful to speak of the patient as consumer. As David Collin, MPH, of the American Cancer Society, Oakland, California, has noted The line between illness and other treatments for cosmetic and enhancement purposes will continue to blur with enhancement becoming the objective of more people and of treatment entrepreneurs. As severe conditions become more manageable the health care market will continue to move toward removing limits and enabling optimum performance. More billions will be spent on troubling, but not life-threatening, conditions. Public acceptance of genetic interventions will follow this trend. 

In Part 3, Cohen focuses on the American Cancer Society and its blacklist of alternative therapies. For starters, he cites an article by Andrew Vickers titled Alternative Cancer Cures Unproven or Disproven in the March/April 2004 issue of CA — A Cancer Journal for Clinicians, a publication of the American Cancer Society. Vickers is described as an Assisting Attending Research Methodologist at Memorial Sloan-Kettering Cancer Center. Asserting that many alternative cancer treatments have been investigated in good quality clinical trials, Vickers states that... 

This work was supported in part by an institutional grant to Harvard University from the American Cancer Society, and in part by a research grant from the National Cancer Institute, National Institutes of Health, Public Health Service. 

Natural IFN-alpha for cancer biotherapy. Dick (Frank) Rauscher for the American Cancer Society and Mary Lasker released funds in the 1970s for flie purchase and investigational use in cancer therapy of a human natural (leukocyte) IFN-alpha preparation. The natural (leukocyte) interferon was prepared hy Kari Cantell at the State Semm Institute and Central Public Health Laboratory, Helsinki, Finland, and was used first by Hans Strander at the Karolinska Institutet, Stockholm, Sweden, most prominently, for the elimination of subclinical metastases from osteosarcoma of the limbs, after the surgical removal of the primary... 

The work done in this laboratory, described in some of the chapters, was supported by a Damon Runyon Fellowship, a Career Development Award from the National Institutes of Health, grants from the American Cancer Society, and grants from the United States Public Health Service. 

This work was supported by Research Grants AM13212 from the US. Public Health Service and NP-176 from the American Cancer Society, during the tenure of an Alfred P. Sloan fellowship. The work with IF-3 was performed in the laboratory of Dr. Grunberg-Manago (Institut de Biologic Physico-Chimique, Paris, France) for whose warm hospitality the author is grateful. 

This work was supported by United States Public Health Service Grants CA 15581 and CA 19334 and American Cancer Society Grant IM-284. I thank Marian Marra for help in writing this chapter and Dr. John Warner for useful discussions. 

This is publication No. 971 of the Cancer Commission of Harvard University. This work was aided by grants from the National Cancer Institute, United States Public Health Service, a grant from the American Cancer Society, Inc., and a grant from the Jane Coffin Childs Memorial Fund for Medical Research. 

These results received extensive media attention, beginning with an article in New Scientist titled "Cheap, safe drug kills most cancers". Subsequently, the American Cancer Society and other medical organizations have received a large volume of public interest and questions regarding DCA. Clinical trials in humans with cancer have not... 

Supported in part by grants from the American Cancer Society and the United States Public Health Service (AM10836). 

Funds for this research were made available by the United States Public Health Service Grant CA 04679 the American Cancer Society Grant P-168-B and Development Award(S. Lande) 1-K3 AM 25757-01, United States Public Health Service. 

It is a pleasure to acknowledge the excellent technical assistance of Ms. Elizabeth Dolci and Ms. Kathy Kohn and the superb typing of Mrs. Anna Polowetzky. This work was supported by Grant IM-67 from the American Cancer Society, Grants HD-05065 and CA-16875 from the U.S. Public Health Services, and Grant GB-35258X from the National Science Foundation. 

The author is grateful to Mr. Simon Halegoua for critical reading of the manuscript. Parts of this article were supported by Public Health Service Grant GM 19043, by American Cancer Society Grant BC-67, and by National Science Foundation Grant BO 42237. 

A somewhat related situation can be used to explain the well-publicized lung-cancer inducing effects of P-carotene in heavy smokers. This subpopulation will have low vitamin C levels and hence damage due to smoke components, such as N02 can produce P-CAR which will reach the lung and initiate damage. In nonsmokers, the vitamin C (or other water-soluble antioxidant) is likely to be present in sufficient concentration to preclude this damaging process. Indeed, this speculation has been promoted by the American Chemical Society as the subject of a press release in 1997 (Bohm et al. 1997). 

---